UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: B | C | F | G | H | J | K | L | M | N | S | T
Number of items: 21.

B

BISHOP, JAM; JACKMAN, AL; HUGHES, L; MARSHAM, P; JONES, TR; CALVERT, AH; (1988) 2-DESAMINO-2-SUBSTITUTED ANALOGS OF 10-PROPARGYL-5,8-DEAZAFOLATE (CB3717) AS INHIBITORS OF THYMIDYLATE SYNTHASE (TS). BRIT J CANCER , 58 (2) 241 - 241.

Bindman, LJ; Meyer, T; Prince, CA; (1988) Postsynaptic events associated with longstanding activity-induced changes in excitability of neocortical neurones. In: Woody, CD and Alkon, DL and McGaugh, JL, (eds.) Cellular Mechanisms of Conditioning and Behavioural Plasticity. (pp. 379-390).

C

CALVERT, AH; HORWICH, A; NEWLANDS, ES; BEGENT, R; RUSTIN, GJS; KAYE, SB; HARRIS, AL; ... SLEVIN, ML; + view all (1988) CARBOPLATIN OR CISPLATIN. LANCET , 2 (8610) 577 - 578.

CALVERT, H; (1988) TOXICITIES OF THE ANTIFOLATE, CB3717. BRIT J CANCER , 58 (5) 688 - 688.

Chester, KA; Lang, B; Gill, J; Vincent, A; Newsomdavis, J; (1988) Lambert-Easton Syndrome antibodies - reaction with membranes from a small cell lung-cancer xenograft. Journal of Neuroimmunology , 18 (2) pp. 97-104.

F

FOSTER, BJ; NEWELL, DR; CARMICHAEL, J; HARRIS, AL; GUMBRELL, LA; WILMAN, DEV; CALVERT, AH; (1988) CLINICAL AND PRECLINICAL PHARMACOKINETIC STUDIES WITH 1-(4-CARBOXYPHENYL)3,3-DIMETHYLTRIAZENE (CB10-277). BRIT J CANCER , 58 (2) 276 - 276.

G

GRAHAM, MA; FOSTER, BJ; NEWELL, DR; GUMBRELL, LA; CALVERT, AH; (1988) PHASE-I STUDY OF THE ANTHRAPYRAZOLE CI-941 WITH PHARMACOKINETICALLY GUIDED DOSE ESCALATION. BRIT J CANCER , 58 (2) 258 - 258.

GUMBRELL, LA; QUALMANN, C; PERREN, TJ; FORGESON, G; CALVERT, AH; THOMPSON, S; RAPEPORT, WG; (1988) AN OPEN PILOT-STUDY OF THE 5-HT3 ANTAGONIST, BRL 43694, AN EFFECTIVE ANTIEMETIC IN REFRACTORY HIGHLY EMETOGENIC CYTO-TOXIC DRUG-INDUCED EMESIS. BRIT J CANCER , 58 (2) 274 - 275.

H

HARTLEY, JA; LOWN, JW; MATTES, WB; KOHN, KW; (1988) DNA-SEQUENCE SPECIFICITY OF ANTITUMOR AGENTS - ONCOGENES AS POSSIBLE TARGETS FOR CANCER-THERAPY. ACTA ONCOL , 27 (5) 503 - 510.

HARTLEY, JA; MATTES, WB; VAUGHAN, K; GIBSON, NW; (1988) DNA-SEQUENCE SPECIFICITY OF GUANINE N7-ALKYLATIONS FOR A SERIES OF STRUCTURALLY RELATED TRIAZENES. CARCINOGENESIS , 9 (4) 669 - 674.

Hartley, JA; Reszka, K; Lown, JW; (1988) Photosensitization by antitumor agents, 4. Anthrapyrazole-photosensitized formation of single strand-breaks in DNA. Free Radic Biol Med , 4 (6) pp. 337-343.

Hartley, JA; Reszka, K; Zuo, ET; Wilson, WD; Morgan, AR; Lown, JW; (1988) Characteristics of the interaction of anthrapyrazole anticancer agents with deoxyribonucleic acids: structural requirements for DNA binding, intercalation, and photosensitization. Mol Pharmacol , 33 (3) pp. 265-271.

J

JACKMAN, AL; TAYLOR, GA; MORAN, R; BISHOP, JAM; PAWELCZAK, K; BALMANNO, K; CALVERT, AH; (1988) SOME BIOLOGICAL PROPERTIES OF 2-DESAMINO-2-SUBSTITUTED-5,8-DEAZAFOLATES THAT INHIBIT THYMIDYLATE SYNTHASE (TS). BRIT J CANCER , 58 (2) 242 - 242.

JUDSON, IR; GORE, ME; GUMBRELL, LA; BALMANNO, K; JODRELL, DI; PERREN, TJ; WILTSHAW, E; ... CALVERT, AH; + view all (1988) A PHASE-II EVALUATION OF TRIMELAMOL (N2,N4,N6-TRIHYDROXYMETHYL-N2,N4,N6-TRIMETHYLMELAMINE) IN STAGE-III-IV OVARIAN-CANCER. BRIT J CANCER , 58 (2) 273 - 273.

K

KOHN, KW; HARTLEY, JA; MATTES, WB; (1988) MECHANISMS OF DNA-SEQUENCE SELECTIVE ALKYLATION OF GUANINE-N7 POSITIONS BY NITROGEN MUSTARDS. BIOCHEM PHARMACOL , 37 (9) 1799 - 1800.

L

Lee, M; Chang, DK; Hartley, JA; Pon, RT; Krowicki, K; Lown, JW; (1988) Structural and dynamic aspects of binding of a prototype lexitropsin to the decadeoxyribonucleotide d(CGCAATTGCG)2 deduced from high-resolution 1H NMR Studies. Biochemistry , 27 (1) pp. 445-455.

Lee, M; Hartley, JA; Pon, RT; Krowicki, K; Lown, JW; (1988) Sequence specific molecular recognition by a monocationic lexitropsin of the decadeoxyribonucleotide d-[CATGGCCATG]2: structural and dynamic aspects deduced from high field 1H-NMR studies. Nucleic Acids Res , 16 (2) pp. 665-684. Gold open access

M

MATTES, WB; HARTLEY, JA; KOHN, KW; MATHESON, DW; (1988) GC-RICH REGIONS IN GENOMES AS TARGETS FOR DNA ALKYLATION. CARCINOGENESIS , 9 (11) 2065 - 2072.

N

NEWELL, DR; MAXWELL, RJ; GRIFFITHS, JR; BISSET, G; HUGHES, L; CALVERT, AH; (1988) PHARMACOKINETIC AND TOXICITY STUDIES WITH C2-DESAMINO-C2-SUBSTITUTED ANALOGS OF THE ANTIFOLATE N10-PROPARGYL-5,8-DIDEAZAFOLIC ACID (CB3717). P AM ASSOC CANC RES , 29 286 - 286.

S

SIKORA, E; NEWELL, DR; JACKMAN, AL; SIMMONDS, AJ; JONES, TR; CALVERT, AH; (1988) DEVELOPMENT OF AN ASSAY FOR THE ESTIMATION OF N10-PROPARGYL-5,8-DIDEAZAFOLIC ACID POLYGLUTAMATES IN TUMOR-CELLS. ANAL BIOCHEM , 172 (2) 344 - 355.

T

TAYLOR, GA; JACKMAN, AL; BALMANNO, K; CALVERT, AH; (1988) INVIVO INHIBITION OF THYMIDYLATE SYNTHASE BY C-2 DESAMINO-C-2-SUBSTITUTED ANALOGS OF N-10-PROPARGYL-5.8 DEAZAFOLIC ACID (CB3717). BRIT J CANCER , 58 (2) 242 - 243.

This list was generated on Sun May 27 01:57:23 2018 BST.